Healthcare -
Biotechnology - NASDAQ - US
$ 36.2
-0.958 %
$ 10.3 B
Market Cap
23.35
P/E
EXEL - NET INCOME
Net Income EXEL - Exelixis, Inc.
208 M
LAST VALUE
-5.18%
2 YEAR CAGR
-21.34%
5 YEAR CAGR
11.04%
10 YEAR CAGR